TRADES
Latest Trades
218
results found
FUND
DATE
ACTION
TICKER
COMPANY
SHARES
% of ETF
ARKF 28 Oct 2021 Buy TDOC TELADOC HEALTH INC 93,448 0.4091
ARKG 28 Oct 2021 Buy TDOC TELADOC HEALTH INC 64,400 0.1344
ARKK 28 Oct 2021 Buy TDOC TELADOC HEALTH INC 456,665 0.3134
ARKW 28 Oct 2021 Buy TDOC TELADOC HEALTH INC 90,039 0.2482
ARKK 18 Oct 2021 Buy TDOC TELADOC HEALTH INC 100 0.0001
ARKK 15 Oct 2021 Buy TDOC TELADOC HEALTH INC 48,448 0.0315
ARKF 12 Oct 2021 Buy TDOC TELADOC HEALTH INC 4,358 0.0179
ARKG 12 Oct 2021 Buy TDOC TELADOC HEALTH INC 83,532 0.1618
ARKK 12 Oct 2021 Buy TDOC TELADOC HEALTH INC 110,791 0.0738
ARKF 11 Oct 2021 Buy TDOC TELADOC HEALTH INC 37,682 0.1513
ARKK 11 Oct 2021 Buy TDOC TELADOC HEALTH INC 173,944 0.1154
ARKG 8 Oct 2021 Buy TDOC TELADOC HEALTH INC 12,496 0.0235
ARKK 8 Oct 2021 Buy TDOC TELADOC HEALTH INC 81,569 0.0528
ARKG 7 Oct 2021 Buy TDOC TELADOC HEALTH INC 81,837 0.1600
ARKW 7 Oct 2021 Buy TDOC TELADOC HEALTH INC 55,191 0.1400
ARKF 6 Oct 2021 Buy TDOC TELADOC HEALTH INC 41,819 0.1600
ARKW 6 Oct 2021 Buy TDOC TELADOC HEALTH INC 31,367 78.2900
ARKK 5 Oct 2021 Buy TDOC TELADOC HEALTH INC 154,175 0.1021
ARKK 23 Sep 2021 Buy TDOC TELADOC HEALTH INC 256,100 0.1671
ARKG 22 Sep 2021 Buy TDOC TELADOC HEALTH INC 49,572 0.0868
ARKK 22 Sep 2021 Buy TDOC TELADOC HEALTH INC 133,063 0.0869
ARKG 21 Sep 2021 Buy TDOC TELADOC HEALTH INC 90,387 0.1594
ARKW 21 Sep 2021 Buy TDOC TELADOC HEALTH INC 98,667 0.2557
ARKF 2 Sep 2021 Buy TDOC TELADOC HEALTH INC 17,173 0.0700
ARKF 1 Sep 2021 Buy TDOC TELADOC HEALTH INC 16,089 0.0632
ARKF 31 Aug 2021 Buy TDOC TELADOC HEALTH INC 18,544 0.0713
ARKF 27 Aug 2021 Buy TDOC TELADOC HEALTH INC 4,793 0.0185
ARKF 25 Aug 2021 Buy TDOC TELADOC HEALTH INC 61,374 0.2412
ARKF 24 Aug 2021 Buy TDOC TELADOC HEALTH INC 12,603 0.0508
ARKG 28 Jul 2021 Buy TDOC TELADOC HEALTH INC 110,009 0.1856
ARKK 28 Jul 2021 Buy TDOC TELADOC HEALTH INC 311,612 0.2043
ARKW 28 Jul 2021 Buy TDOC TELADOC HEALTH INC 292,221 0.6918
ARKF 27 Jul 2021 Buy TDOC TELADOC HEALTH INC 89,815 0.3499
ARKW 27 Jul 2021 Buy TDOC TELADOC HEALTH INC 89,288 0.2239
ARKF 26 Jul 2021 Buy TDOC TELADOC HEALTH INC 250,353 0.9617
ARKG 5 May 2021 Buy TDOC TELADOC HEALTH INC 114,199 0.2065
ARKK 5 May 2021 Buy TDOC TELADOC HEALTH INC 133,812 0.1010
ARKW 5 May 2021 Buy TDOC TELADOC HEALTH INC 77,794 0.2031
ARKK 4 May 2021 Buy TDOC TELADOC HEALTH INC 143,204 0.1045
ARKG 30 Apr 2021 Buy TDOC TELADOC HEALTH INC 80,765 0.1446
ARKK 30 Apr 2021 Buy TDOC TELADOC HEALTH INC 127,422 0.0942
ARKW 30 Apr 2021 Buy TDOC TELADOC HEALTH INC 52,854 0.1349
ARKG 29 Apr 2021 Buy TDOC TELADOC HEALTH INC 166,635 0.2936
ARKK 29 Apr 2021 Buy TDOC TELADOC HEALTH INC 424,255 0.3033
ARKW 29 Apr 2021 Buy TDOC TELADOC HEALTH INC 125,379 0.3194
ARKK 29 Mar 2021 Buy TDOC TELADOC HEALTH INC 176,108 0.1456
ARKG 25 Mar 2021 Buy TDOC TELADOC HEALTH INC 80,118 0.1499
ARKK 25 Mar 2021 Buy TDOC TELADOC HEALTH INC 180,692 0.1456
ARKW 25 Mar 2021 Buy TDOC TELADOC HEALTH INC 58,186 0.1518
ARKW 19 Mar 2021 Buy TDOC TELADOC HEALTH INC 45,469 0.1145
ARKG 18 Mar 2021 Buy TDOC TELADOC HEALTH INC 46,148 0.0889
ARKK 18 Mar 2021 Buy TDOC TELADOC HEALTH INC 159,440 0.1271
ARKG 17 Mar 2021 Buy TDOC TELADOC HEALTH INC 78,371 0.1432
ARKK 17 Mar 2021 Buy TDOC TELADOC HEALTH INC 174,957 0.1305
ARKW 17 Mar 2021 Buy TDOC TELADOC HEALTH INC 52,148 0.1262
ARKK 12 Mar 2021 Buy TDOC TELADOC HEALTH INC 162,624 0.1281
ARKK 11 Mar 2021 Buy TDOC TELADOC HEALTH INC 270,500 0.2199
ARKK 5 Mar 2021 Buy TDOC TELADOC HEALTH INC 162,549 0.1433
ARKK 4 Mar 2021 Buy TDOC TELADOC HEALTH INC 282,246 0.2547
ARKK 3 Mar 2021 Buy TDOC TELADOC HEALTH INC 226,209 0.2047
ARKW 3 Mar 2021 Buy TDOC TELADOC HEALTH INC 78,940 0.2095
ARKK 1 Mar 2021 Buy TDOC TELADOC HEALTH INC 111,041 0.1025
ARKW 1 Mar 2021 Buy TDOC TELADOC HEALTH INC 88,691 0.2349
ARKG 26 Feb 2021 Buy TDOC TELADOC HEALTH INC 236,890 0.4865
ARKK 26 Feb 2021 Buy TDOC TELADOC HEALTH INC 236,520 0.2223
ARKF 25 Feb 2021 Buy TDOC TELADOC HEALTH INC 39,654 0.2038
ARKK 25 Feb 2021 Buy TDOC TELADOC HEALTH INC 393,495 0.3841
ARKW 25 Feb 2021 Buy TDOC TELADOC HEALTH INC 151,423 0.4343
ARKG 19 Jan 2021 Buy TDOC TELADOC HEALTH INC 45,371 0.1000
ARKF 15 Jan 2021 Buy TDOC TELADOC HEALTH INC 21,394 0.2000
ARKG 15 Jan 2021 Buy TDOC TELADOC HEALTH INC 70,401 0.1554
ARKF 14 Jan 2021 Buy TDOC TELADOC HEALTH INC 21,394 0.2000
ARKG 4 Jan 2021 Buy TDOC TELADOC HEALTH INC 97,892 0.2518
ARKG 29 Dec 2020 Buy TDOC TELADOC HEALTH INC 118,367 0.3152
ARKG 28 Dec 2020 Buy TDOC TELADOC HEALTH INC 194,438 0.5044
ARKG 24 Dec 2020 Buy TDOC TELADOC HEALTH INC 19,262 0.0515
ARKG 23 Dec 2020 Buy TDOC TELADOC HEALTH INC 181,803 0.5012
ARKG 18 Dec 2020 Buy TDOC TELADOC HEALTH INC 36,195 0.1150
ARKG 17 Dec 2020 Buy TDOC TELADOC HEALTH INC 26,999 0.0856
ARKG 16 Dec 2020 Buy TDOC TELADOC HEALTH INC 63,575 0.2028
ARKK 16 Dec 2020 Buy TDOC TELADOC HEALTH INC 391,636 0.4493
ARKW 16 Dec 2020 Buy TDOC TELADOC HEALTH INC 67,490 0.2489
ARKG 15 Dec 2020 Buy TDOC TELADOC HEALTH INC 90,962 0.3025
ARKK 15 Dec 2020 Buy TDOC TELADOC HEALTH INC 27,731 0.0334
ARKF 9 Dec 2020 Buy TDOC TELADOC HEALTH INC 43,089 0.6062
ARKG 9 Dec 2020 Buy TDOC TELADOC HEALTH INC 21,285 0.0780
ARKK 9 Dec 2020 Buy TDOC TELADOC HEALTH INC 57,465 0.0734
ARKW 7 Dec 2020 Buy TDOC TELADOC HEALTH INC 38,399 0.1686
ARKK 3 Dec 2020 Buy TDOC TELADOC HEALTH INC 91,819 0.1350
ARKK 2 Dec 2020 Buy TDOC TELADOC HEALTH INC 77,741 0.1141
ARKG 24 Nov 2020 Buy TDOC TELADOC HEALTH INC 33,376 0.1708
ARKF 17 Nov 2020 Buy TDOC TELADOC HEALTH INC 29,767 0.4994
ARKG 16 Nov 2020 Buy TDOC TELADOC HEALTH INC 83,995 0.4505
ARKK 16 Nov 2020 Buy TDOC TELADOC HEALTH INC 128,386 0.2050
ARKW 16 Nov 2020 Buy TDOC TELADOC HEALTH INC 43,073 0.2261
ARKK 13 Nov 2020 Buy TDOC TELADOC HEALTH INC 152,196 0.2496
ARKW 13 Nov 2020 Buy TDOC TELADOC HEALTH INC 39,450 0.2184
ARKG 10 Nov 2020 Buy TDOC TELADOC HEALTH INC 35,533 0.1946
ARKK 10 Nov 2020 Buy TDOC TELADOC HEALTH INC 120,560 0.1988
ARKW 10 Nov 2020 Buy TDOC TELADOC HEALTH INC 34,417 0.1950
Latest Blogs
ARK by Cathie Wood is still suffering a year after its apex.

Cathie Wood's flagship exchange-traded fund hit an all-time high in February of this year. Her preferred disruptive-tech chasing strategy may still be in for a lot of suffering after a year and a 53 percent fall.

After a dramatic decline last month, the ARK Innovation ETF (ticker: ARKK) has steadied off - it's practically flat in February – but the headwinds surrounding its speculative growth picks are just becoming more vital. Many businesses that thrived during the pandemic are being hammered by the economic reopening, not only because yields are rising as investors prepare for the US Federal Reserve to raise interest rates, which is terrible news for unprofitable businesses, but also because the economic reopening is hammering many of the businesses that thrived during the pandemic.

Roku, Teladoc, and Zoom, all winners in the work-from-home era, have had their stock prices plummet by as much as 74% in the past year.

Short bets against ARK, according to IHS Markit data, hit a fresh high of 11.4 percent of outstanding shares this week. The Tuttle Capital Short Innovation ETF (SARK), which beats the ARK, now has assets worth more than $US300 million ($416 million).

"Those equities are supported by speculation, and speculation pays less well when the Fed raises rates," said Brent Schutte, chief investment strategist at Northwestern Mutual Wealth Management Co. "Much of what's happening in the market reminds me of what happened in the late 1990s when market segments were bid up to levels based on future assumptions."

Because its price chart resembles that of the Nasdaq index of technology businesses from more than two decades ago, analogies to that period and the dot-com implosion that followed are becoming more common in discussions of ARK.

"Today marks the 253rd trading day from ARK's all-time high," Jessica Rabe, co-founder of DataTrek Research, wrote in a Tuesday note, "while the Nasdaq was down 60% from its dot-com bubble top on the same day in 2001."

"If 2000/2001 analog holds, we should see ARK continuing to fall over the following three weeks. The Nasdaq dropped 18.7% in the next 16 trading days "recent."

Net flows are positive.

The better news for investors and Ms. Wood is that there may be some immediate respite. The Nasdaq rose 41% in six weeks in 2001 before falling.

The ARK Investment Management did not respond to a request for comment.

Most of ARK's $US15 billion asset loss has been attributed to bad performance, a plus for the company. Since the fund achieved an intraday high of $US159.70 a year ago this week, investors have withdrawn only around $US465 million, and ARK's net flows this year are positive despite a more than 20% drop.

This exceptional loyalty prevents a worsening situation and allows Wood's approach to recovering. The star fund manager has consistently emphasized that her funds have a five-year investment horizon and that she believes in many good options.

Mr. Schutte, on the other hand, says the drop is understandable because several of the company's biggest bets, such as Teladoc and Zoom, are becoming less significant as COVID-19 approaches.

"During the pandemic, there were a lot of questions about what would happen to society and how we'd go about our lives," he added.

"You drew in new investors who wanted to know "what are the upcoming themes I should invest in?" I believe you got a washout of it as well."

On Friday, Cathie Wood sold $148.9 million worth of Palantir stock, halving her exposure.

Ark Investment Management, run by Cathie Wood, sold more Palantir Technologies Inc PLTR -6.39 percent shares on Friday, cutting its stake in the Peter Thiel-backed company.

According to Friday's closing price, the famous investment management firm sold 13.5 million shares of the big data company, valued at $148.9 million.

Palantir's stock fell 6.4 percent to $11.02 per share on Friday. The stock has lost 16% of its value in the last week.

Before Friday's trade, Ark Invest held 25.53 million shares in Palantir, suggesting that the famous stock picker had trimmed over 52 percent of its total keeping a day later.

After the business disclosed lower-than-expected fourth-quarter earnings before the market opened on Thursday, Ark Invest, located in St. Petersburg, California, dumped shares in Palantir for the second time.

The software firm, well-known for its work with government organizations, posted earnings of 2 cents per share, falling short of the analyst consensus of 4 cents. The company recorded quarterly revenues of $432.87 million, higher than the $417.69 million predicted by analysts.

Palantir's stock had been sold for 4.77 million shares by the investment firm the day before.

All six of Ark Invest's active exchange-traded funds own Palantir stock, including the flagship Ark Innovation ETF ARKK -4.88 percent.

Before the recent sell-off, Ark Invest had been stockpiling Palantir shares for months.

Cathie Wood appeared on television to defend her ARK funds' dismal performance. It didn't go quite as planned.

The Ark Innovation ETF (ARKK), Cathie Wood's flagship fund, is down 30% year to date and more volatile than almost any other fund on the market. On CNBC's Halftime Report, Wood jumped at the chance to defend the fund and its deflated price, which is currently $68.80, down from $155 a year ago.

"We've seen a significant decline," Wood said, adding, "We feel innovation is at bargain basement zone." Even though her ETF was underperforming, she emphasized that her companies were still "very inexpensive" and that the current fund loss was temporary. When the call's 40 free minutes were finished, Zoom gave her an extra 10 minutes to complete the interview.

Having Zoom check to see whether she was "running out of time?" Wood, who has been aggressively buying up shares in Zoom and other IT firms that have fallen from their pandemic highs, was unhappy. Zoom, like Wood's other significant tech holdings, Teladoc Health, Roku, and Roblox, is down 20% to 40% year to date as investors worry about rising interest and inflation rates.

However, a significant chunk of the interview was devoted to a personal assault on Cathie Wood, who was named the most excellent stock picker in 2020 by Bloomberg's then-Editor-in-Chief Matthew Winkler after correctly forecasting that Tesla will one day be valued at more than $1 trillion.

Wood bluntly ignored Tuttle Capital Management's Short Innovation ETF (SARK), which tracks the inverse performance of ARKK using swaps contracts for the sole purpose of betting against Cathie Wood's selections. "They're not conducting any research." She explained, "All they're doing is shorting innovation."

Of course, SARK is betting against Cathie Woods, not on innovation. "Well, we stand for invention," Wood responded. The SARK ETF has gained 55 percent since its debut, whereas the ARKK ETF has declined by 42 percent.

Tuttle Capital Management CEO Matthew Tuttle chimed in on the SARK ETF, calling it a "tool" for investors. According to SARK, "to convey a negative view of the market, innovative enterprises, the current rising rate environment, or a [specific] portfolio manager if they wish." "It's un-American not to have options in the marketplace," Tuttle told Insider on Thursday.

In any event, Wood is making progress. Her main concern currently is bearish calls on her ETF. "Our major concern is that our investors convert temporary losses into long-term losses," Wood continued.